These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8882421)

  • 1. Anti-ganglioside antibodies in new onset type 1 diabetic patients and high risk subjects.
    Tiberti C; Dotta F; Anastasi E; Torresi P; Multari G; Vecci E; Andreani D; Di Mario U
    Autoimmunity; 1995; 22(1):43-8. PubMed ID: 8882421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmunity to the GM2-1 islet ganglioside before and at the onset of type I diabetes.
    Dotta F; Gianani R; Previti M; Lenti L; Dionisi S; D'Erme M; Eisenbarth GS; Di Mario U
    Diabetes; 1996 Sep; 45(9):1193-6. PubMed ID: 8772721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies to the GM2-1 islet ganglioside and to GAD-65 at type 1 diabetes onset.
    Dotta F; Falorni A; Tiberti C; Dionisi S; Anastasi E; Torresi P; Lernmark A; Di Mario U
    J Autoimmun; 1997 Dec; 10(6):585-8. PubMed ID: 9451598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gangliosides and autoimmune diabetes.
    Misasi R; Dionisi S; Farilla L; Carabba B; Lenti L; Di Mario U; Dotta F
    Diabetes Metab Rev; 1997 Sep; 13(3):163-79. PubMed ID: 9307889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies against ganglioside GT3 in the sera of patients with type I diabetes mellitus.
    Gillard BK; Thomas JW; Nell LJ; Marcus DM
    J Immunol; 1989 Jun; 142(11):3826-32. PubMed ID: 2654294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat pancreatic ganglioside expression: differences between a model of autoimmune islet B cell destruction and a normal strain.
    Dotta F; Tiberti C; Previti M; Anastasi E; Andreani D; Lenti L; Pontieri GM; Gianani R; Appel MC; Eisenbarth GS
    Clin Immunol Immunopathol; 1993 Feb; 66(2):143-9. PubMed ID: 8453786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic islet ganglioside expression in nonobese diabetic mice: comparison with C57BL/10 mice and changes after autoimmune beta-cell destruction.
    Dotta F; Peterson LB; Previti M; Metzger J; Tiberti C; Anastasi E; Zoppitelli P; Wicker LS; Di Mario U
    Endocrinology; 1992 Jan; 130(1):37-42. PubMed ID: 1727711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target antigens in autoimmune diabetes: pancreatic gangliosides.
    Dionisi S; Dotta F; Diaz-Horta O; Carabba B; Viglietta V; Di Mario U
    Ann Ist Super Sanita; 1997; 33(3):433-5. PubMed ID: 9542277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of progression to diabetes of low titer ICA-positive first-degree relatives of type I diabetics in southern Germany.
    Ziegler AG; Baumgartl HJ; Standl E; Mehnert H
    J Autoimmun; 1990 Oct; 3(5):619-24. PubMed ID: 2252530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-ganglioside autoantibodies in type 1 diabetes.
    Lucchetta M; Rudilosso S; Costa S; Bruttomesso D; Ruggero S; Toffanin E; Faggian D; Plebani M; Battistin L; Alaedini A; Briani C
    Muscle Nerve; 2010 Jan; 41(1):50-3. PubMed ID: 19768773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum anti-ganglioside IgM antibodies in soft tissue sarcoma: clinical prognostic implications.
    Perez CA; Ravindranath MH; Soh D; Gonzales A; Ye W; Morton DL
    Cancer J; 2002; 8(5):384-94. PubMed ID: 12416896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet cell-specific autoantibodies in children with insulin-dependent diabetes mellitus and their siblings at clinical manifestation of the disease. Childhood Diabetes in Finland Study Group.
    Vähäsalo P; Knip M; Karjalainen J; Tuomilehto-Wolf E; Lounamaa R; Akerblom HK
    Eur J Endocrinol; 1996 Dec; 135(6):689-95. PubMed ID: 9025714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of islet cell antibodies.
    Lipton R; LaPorte RE
    Epidemiol Rev; 1989; 11():182-203. PubMed ID: 2680555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus.
    Saariaho AH; Vuorela A; Freitag TL; Pizza F; Plazzi G; Partinen M; Vaarala O; Meri S
    J Autoimmun; 2015 Sep; 63():68-75. PubMed ID: 26227560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-lymphocyte changes linked to autoantibodies. Association of insulin autoantibodies with CD4+CD45R+ lymphocyte subpopulation in prediabetic subjects.
    Faustman D; Schoenfeld D; Ziegler R
    Diabetes; 1991 May; 40(5):590-7. PubMed ID: 1827080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-cell markers and autoantigen expression by a human insulinoma cell line: similarities to native beta cells.
    Cavallo MG; Dotta F; Monetini L; Dionisi S; Previti M; Valente L; Toto A; Di Mario U; Pozzilli P
    J Endocrinol; 1996 Jul; 150(1):113-20. PubMed ID: 8708552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
    Hummel M; Durinovic-Bello I; Ziegler AG
    J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin G-class mouse monoclonal antibodies to major brain gangliosides.
    Schnaar RL; Fromholt SE; Gong Y; Vyas AA; Laroy W; Wayman DM; Heffer-Lauc M; Ito H; Ishida H; Kiso M; Griffin JW; Shiekh KA
    Anal Biochem; 2002 Mar; 302(2):276-84. PubMed ID: 11878808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The GM2-1 ganglioside islet autoantigen in insulin-dependent diabetes mellitus is expressed in secretory granules and is not beta-cell specific.
    Dotta F; Previti M; Neerman-Arbez M; Dionisi S; Cucinotta D; Lenti L; Di Mario U; Halban PA
    Endocrinology; 1998 Jan; 139(1):316-9. PubMed ID: 9421429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.